NCT02936791Recruiting
Early PKD Observational Cohort Study
Source: ClinicalTrials.gov · Last updated 27 Apr 2026
Brief summary (registry, in English)
This observational study will collect blood and urine and clinical information from individuals with early-stages of polycystic kidney disease (PKD), their unaffected siblings and normal volunteers to create a biobank, also called a biorepository. The long-term goal is to develop new knowledge on biological markers or biomarkers that indicate changes in the disease progression. An understanding of biomarkers for early renal cyst growth will benefit PKD patients as new therapies are being developed and tested.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 250 (estimated)
- First submitted
- 10 Oct 2016
- Start date
- 1 Apr 2016
- Primary completion date
- 30 Jun 2030
- Lead sponsor
- University of Kansas Medical Center
- Diseases
- Polycystic kidney disease
- NCT number
- NCT02936791
What you commit to
- Study type: Observational
- Planned participants: 250
- From 1 Apr 2016 to the primary completion date, 30 Jun 2030
- 3 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Non-insulin or insulin-dependent diabetes mellitus
- Systemic illness (i.e.systemic lupus erythematosus, vasculitis)
Other
- Unable to provide written informed consent
- Unavailable for magnetic resonance imaging (MRI) and blood/urine collection
Who the study is looking for
- Inclusion for early stage autosomal dominant polycystic kidney disease (ADPKD):
- Family history of PKD
- All races and ethnic groups
- Glomerular filtration rate (GFR) \>80 ml/min per 1.73 m2
- Inclusion for Healthy Volunteers:
- Male or female with no family history of kidney disease
- All races and ethnic groups
- Normal GFR
Age in the registry: 4 years to 35 years · Sex: All · Accepts healthy volunteers
Sites (3)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| University of Chicago Coordinator of this site? Confirm its status | Chicago | United States | Recruiting |
| Children's Mercy Hospital Coordinator of this site? Confirm its status | Kansas City | United States | Recruiting |
| University of Kansas Medical Center Coordinator of this site? Confirm its status | Kansas City | United States | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.